Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Providence Therapeutics logo — Where Hope and Science Intersect

Providence Therapeutics

Where Hope and Science Intersect

Founded 2015 Canada Calgary, Canada 56 employees Total: $5.60M Biotechnology, Health Care +1

General Information

Company Name Providence Therapeutics
Founded Year 2015
Location Canada Calgary, Canada
Employees 56
Industries Biotechnology, Health Care, Health and Wellness
Business Model B2B, Platform, B2B2B
Revenue Model Licensing, Service Fee, Project Based
Social

BounceWatch is an independent company data service, not affiliated with Providence Therapeutics. To contact Providence Therapeutics, visit providencetherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Providence Therapeutics compare?

A PDF of Providence Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Providence Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Providence Therapeutics

Providence Therapeutics, embodying the ethos of "Where Hope and Science Intersect," is a promising clinical-stage biotechnology company established in 2015 and headquartered in Canada. The company specializes in drug development through its robust mRNA Medicines platform, encompassing three integrated systems: the mRNA Medicines Platform, the proprietary INTENT™ Lipid Nanoparticle (LNP) Platform, and a scalable Manufacturing Platform.

Providence differentiates itself with its end-to-end solution capabilities, offering codon-optimized ultrapure mRNA and application-optimized LNPs. Its INTENT™ LNP platform showcases innovative lipids designed for efficacy in oncology, infectious diseases, and gene delivery.

The company's last financial influx was a $2.12M grant investment on 01 December 2021, backed by the prestigious Bill & Melinda Gates Foundation. This support underscores confidence in Providence's potential to advance health care solutions within the Biotechnology and Health and Wellness sectors.

Business keywords: Clinical-Stage Biotechnology, mRNA Medicines Platform, Lipid Nanoparticle Platform, Manufacturing Platform, Cancer Vaccines, Personalized Medicine, mRNA Therapeutics, Ovarian Cancer Treatment, Oncology, Infectious Diseases, Gene Delivery, Tumor Mutation Identification, Immune Response Optimization, Biotech Innovation

Services & Products

Development of mRNA-based therapeutics for oncology and infectious diseases
Clinical research and trials
Provision of mRNA platform technology for drug development
Partnerships with industry players for therapeutic development

Target Customers

Biotech industry players Therapeutics developers Scientific community Academic institutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $2.12M 1
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
01 Dec 2021
Early VC $3.48M -
01 Jul 2020

Providence Therapeutics Alternatives & Competitors

View All Alternatives
Providence Therapeutics vs
Moderna
Moderna United States

Our mission is to deliver the greatest possible impact to people through mRNA medicines.

Grant
6245 employees
Biotechnology, Health Care
Providence Therapeutics vs
Senda Biosciences
Senda Biosciences United States

Harnessing nature to program targeted, potent and tunable medicines

Merged
8 employees
Biotechnology, Health Care
Providence Therapeutics vs
OS Therapies
OS Therapies United States

Targeting Osteosarcoma, Breast Cancer and other Solid Tumors to prevent HER2-metastasis and destroy...

Debt Financing
8 employees
Health Care, Health and Wellness
View all alternatives

FAQ About Providence Therapeutics

Where Hope and Science Intersect
Providence Therapeutics was founded in 2015.
Providence Therapeutics is headquartered in Calgary, Canada.
Providence Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Clinical-Stage Biotechnology, mRNA Medicines Platform, Lipid Nanoparticle Platform and Manufacturing Platform. Its customers include Biotech industry players, Therapeutics developers and Scientific community.
Providence Therapeutics has a B2B, Platform and B2B2B business model. Its revenue comes from Licensing, Service Fee and Project Based.
Providence Therapeutics has approximately 56 employees.
Providence Therapeutics has completed 2 funding rounds, raising a total of $5.60M.
Providence Therapeutics offers: Development of mRNA-based therapeutics for oncology and infectious diseases, Clinical research and trials, Provision of mRNA platform technology for drug development, Partnerships with industry players for therapeutic development.
Top alternatives and competitors to Providence Therapeutics include Moderna, Senda Biosciences, OS Therapies, Imvax, Inc., Hopewell Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Providence Therapeutics and Moderna are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Providence Therapeutics, https://bouncewatch.com/company/providence-therapeutics, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes